Literature DB >> 33252997

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease.

Laure Gallay1, Yurdagül Uzunhan2, Raphael Borie3, Romain Lazor4, Pierre Rigaud5, Sylvain Marchand-Adam6, Sandrine Hirschi7, Dominique Israel-Biet8, Victor Valentin9, Vincent Cottin1.   

Abstract

Entities:  

Year:  2021        PMID： 33252997     DOI： 10.1164/rccm.202007-2638LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019.

Authors:  Daniel A Puebla Neira; Abigail Watts; Justin Seashore; Alexander Duarte; Shawn P Nishi; Efstathia Polychronopoulou; Yong-Fang Kuo; Jacques Baillargeon; Gulshan Sharma
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

2.  The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients.

Authors:  Zarir Farokh Udwadia; Parvaiz A Koul; Sahajal Dhooria
Journal:  Lung India       Date:  2021-03

Review 3.  Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.

Authors:  Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive
Journal:  Arch Bronconeumol       Date:  2022-04-15       Impact factor: 6.333

4.  COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.

Authors:  Yosuke Goto; Koji Sakamoto; Jun Fukihara; Atsushi Suzuki; Norihito Omote; Akira Ando; Yuichiro Shindo; Naozumi Hashimoto
Journal:  Front Med (Lausanne)       Date:  2022-02-03

5.  Interstitial lung disease before and after COVID-19: a double threat?

Authors:  Claudia Valenzuela; Grant Waterer; Ganesh Raghu
Journal:  Eur Respir J       Date:  2021-12-02       Impact factor: 16.671

Review 6.  Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.

Authors:  Joon Young Choi; Jin Woo Song; Chin Kook Rhee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-27

7.  Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs.

Authors:  Takafumi Yamaya; Eri Hagiwara; Tomohisa Baba; Tae Iwasawa; Takashi Ogura
Journal:  J Infect Chemother       Date:  2022-04-11       Impact factor: 2.065

8.  Survivorship Analysis in Asymptomatic COVID-19+ Hip Fracture Patients: Is There an Increase in Mortality?

Authors:  Mason D Vialonga; Luke G Menken; Alex Tang; John W Yurek; Li Sun; John J Feldman; Frank A Liporace; Richard S Yoon
Journal:  Hip Pelvis       Date:  2022-03-07

9.  Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease.

Authors:  John A Mackintosh; Marc Lipman; David M Lowe; Elisabetta A Renzoni
Journal:  Lancet Respir Med       Date:  2021-07-15       Impact factor: 30.700

10.  How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group.

Authors:  Francesca Ferretti; Rosanna Cannatelli; Maurizio Benucci; Stefania Carmagnola; Emilio Clementi; Piergiorgio Danelli; Dario Dilillo; Paolo Fiorina; Massimo Galli; Maurizio Gallieni; Giovanni Genovese; Valeria Giorgi; Alessandro Invernizzi; Giovanni Maconi; Jeanette A Maier; Angelo V Marzano; Paola S Morpurgo; Manuela Nebuloni; Dejan Radovanovic; Agostino Riva; Giuliano Rizzardini; Gianmarco Sabiu; Pierachille Santus; Giovanni Staurenghi; Gianvincenzo Zuccotti; Pier Carlo Sarzi-Puttini; Sandro Ardizzone
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.